Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer | |
Shen, Yan-Wei; Zhang, Xiao-Man; Li, Shu-Ting; Lv, Meng; Yang, Jiao; Wang, Fan; Chen, Zhe-Ling; Wang, Bi-Yuan; Li, Pan; Chen, Ling | |
刊名 | ONCOTARGETS AND THERAPY
![]() |
2016 | |
卷号 | 9期号:[db:dc_citation_issue]页码:929-935 |
关键词 | icotinib hydrochloride lung neoplasms first-line treatment |
ISSN号 | 1178-6930 |
DOI | [db:dc_identifier_doi] |
URL标识 | 查看原文 |
WOS记录号 | [DB:DC_IDENTIFIER_WOSID] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3225406 |
专题 | 西安交通大学 |
推荐引用方式 GB/T 7714 | Shen, Yan-Wei,Zhang, Xiao-Man,Li, Shu-Ting,et al. Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer[J]. ONCOTARGETS AND THERAPY,2016,9([db:dc_citation_issue]):929-935. |
APA | Shen, Yan-Wei.,Zhang, Xiao-Man.,Li, Shu-Ting.,Lv, Meng.,Yang, Jiao.,...&Yang, Jin.(2016).Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer.ONCOTARGETS AND THERAPY,9([db:dc_citation_issue]),929-935. |
MLA | Shen, Yan-Wei,et al."Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer".ONCOTARGETS AND THERAPY 9.[db:dc_citation_issue](2016):929-935. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论